TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
What is the latest Revenue of TRIDENT LIFELINE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹22 Cr |
How is Revenue of TRIDENT LIFELINE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 94.86 | |
| Mar2024 | ₹45 Cr | 40.82 | |
| Mar2023 | ₹32 Cr | 45.59 | |
| Mar2022 | ₹22 Cr | - | |
Compare Revenue of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹324.3 Cr | -4% | 3.8% | 4.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -4% |
3.8% |
4.6% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses